Cancer and molecular medicine
The Cancer and Molecular Medicine (CMM) program is a translational and interdisciplinary Ph.D. track in the Center for Clinical and Translational Research. This program trains students to perform translational research in cancer and molecular medicine. This requires a background and the necessary vocabulary to communicate with both scientists and clinicians, and the research skills to be able to bridge bench and clinical science. The marriage of cancer and molecular medicine blends established cancer biology with an emerging field, molecular medicine.
Three new students joined the CMM program in 2012, and have entered the laboratories of faculty members in the School of Medicine. Jeremy Meier is working with Andrew Larner, M.D., Ph.D., in Biochemistry and Molecular Biology, Lauren Folgosa is working with Daniel Conrad, Ph.D., in Microbiology and Immunology, and Reed McDonagh is working with co-mentors Ross B. Mikkelsen, Ph.D. and Jamal Zweit, Ph.D., in Radiology. All three of the students this year are M.D./Ph.D. candidates, but the program plans to admit Ph.D. and M.D./Ph.D. candidates in 2013. The students will have both a research and a clinical mentor, to foster the translational aspects of their projects.
To see the curriculum for the program, and to apply, please refer to the VCU Bulletin. For more information about the CMM program, please contact one of the CMM program co-directors, Joyce Lloyd, Ph.D., or Devanand Sarkar, M.B.B.S., Ph.D.